|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003297,
umls-concept:C0004083,
umls-concept:C0013216,
umls-concept:C0025853,
umls-concept:C0032529,
umls-concept:C0057223,
umls-concept:C0061851,
umls-concept:C0205250,
umls-concept:C0332293,
umls-concept:C0337900,
umls-concept:C0376622,
umls-concept:C0597357,
umls-concept:C0871261,
umls-concept:C1332830,
umls-concept:C1415812,
umls-concept:C1516213,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2011-9-29
|
|
pubmed:abstractText |
Suboptimal treatment of chemotherapy-induced nausea and vomiting and unsatisfactory response to antiemetic drugs cause impairment of cancer patient's daily functioning. This study was aimed to investigate the association of selected germline polymorphisms with ondansetron and metoclopramide response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ABCB1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Antiemetics,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP2D6,
http://linkedlifedata.com/resource/pubmed/chemical/HTR3B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Metoclopramide,
http://linkedlifedata.com/resource/pubmed/chemical/Ondansetron,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin, 5-HT3
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1465-3621
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1168-76
|
|
pubmed:meshHeading |
pubmed-meshheading:21840870-Antiemetics,
pubmed-meshheading:21840870-Antineoplastic Agents,
pubmed-meshheading:21840870-Cisplatin,
pubmed-meshheading:21840870-Cytochrome P-450 CYP2D6,
pubmed-meshheading:21840870-Female,
pubmed-meshheading:21840870-Haplotypes,
pubmed-meshheading:21840870-Humans,
pubmed-meshheading:21840870-Indonesia,
pubmed-meshheading:21840870-Male,
pubmed-meshheading:21840870-Metoclopramide,
pubmed-meshheading:21840870-Middle Aged,
pubmed-meshheading:21840870-Nausea,
pubmed-meshheading:21840870-Neoplasms,
pubmed-meshheading:21840870-Ondansetron,
pubmed-meshheading:21840870-P-Glycoprotein,
pubmed-meshheading:21840870-Polymorphism, Single Nucleotide,
pubmed-meshheading:21840870-Receptors, Serotonin, 5-HT3,
pubmed-meshheading:21840870-Vomiting
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
|
|
pubmed:affiliation |
Department of Pharmacy, Ahmad Dahlan University, Yogyakarta, Indonesia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
